Opko Health (OPK) : Oracle Investment Management Inc scooped up 200 additional shares in Opko Health during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 3,914,000 shares of Opko Health which is valued at $39,374,840.Opko Health makes up approximately 7.20% of Oracle Investment Management Inc’s portfolio.
Other Hedge Funds, Including , Marathon Capital Management added OPK to its portfolio by purchasing 15,000 company shares during the most recent quarter which is valued at $150,900. Opko Health makes up approx 0.08% of Marathon Capital Management’s portfolio.Essex Investment Management Co boosted its stake in OPK in the latest quarter, The investment management firm added 41,607 additional shares and now holds a total of 377,496 shares of Opko Health which is valued at $3,756,085. Opko Health makes up approx 0.60% of Essex Investment Management Co’s portfolio.
Opko Health opened for trading at $9.31 and hit $9.54 on the upside on Thursday, eventually ending the session at $9.29, with a gain of 2.09% or 0.19 points. The heightened volatility saw the trading volume jump to 35,15,257 shares. Company has a market cap of $5,113 M.
On the company’s financial health, Opko Health reported $0.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.03. The company had revenue of $357.10 million for the quarter, compared to analysts expectations of $324.11 million. The company’s revenue was up 742.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.09 EPS.
Many Wall Street Analysts have commented on Opko Health. Company shares were Reiterated by Standpoint Research on Jun 21, 2016 to “Buy”, Firm has raised the Price Target to $ 18 from a previous price target of $16 .Standpoint Research Initiated Opko Health on Jun 3, 2016 to “Buy”, Price Target of the shares are set at $16.
OPKO Health Inc. (OPKO) is a biopharmaceutical and diagnostics company. The Company is involved in developing a range of solutions to diagnose treat and prevent various conditions including point-of-care tests laboratory developed tests (LDTs) molecular diagnostics tests and pharmaceuticals and vaccines. It operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment consists of two operating segments pharmaceutical research and development segment and pharmaceutical operations. Its diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. It owns pharmaceutical operations in Chile Spain Mexico Israel Uruguay and Brazil. The product pipeline includes several pharmaceutical compounds and technologies in research and development for a range of indications and conditions.